Simple Cardiovascular Risk Stratification by Replacing Total Serum Cholesterol with Anthropometric Measures: The MORGAM Prospective Cohort Project
Overview
Authors
Affiliations
To assess whether anthropometric measures (body mass index [BMI], waist-hip ratio [WHR], and estimated fat mass [EFM]) are independently associated with major adverse cardiovascular events (MACE), and to assess their added prognostic value compared with serum total-cholesterol. The study population comprised 109,509 individuals (53% men) from the MORGAM-Project, aged 19-97 years, without established cardiovascular disease, and not on antihypertensive treatment. While BMI was reported in all, WHR and EFM were reported in ∼52,000 participants. Prognostic importance of anthropometric measurements and total-cholesterol was evaluated using adjusted Cox proportional-hazards regression, logistic regression, area under the receiver-operating-characteristic curve (AUC), and net reclassification improvement (NRI). The primary endpoint was MACE, a composite of stroke, myocardial infarction, or death from coronary heart disease. Age interacted significantly with anthropometric measures and total-cholesterol on MACE (P ≤ 0.003), and therefore age-stratified analyses (<50 versus ≥ 50 years) were performed. BMI, WHR, EFM, and total-cholesterol were independently associated with MACE (P ≤ 0.003) and resulted in significantly positive NRI when added to age, sex, smoking status, and systolic blood pressure. Only total-cholesterol increased discrimination ability (AUC difference; P < 0.001). In subjects < 50 years, the prediction model with total-cholesterol was superior to the model including BMI, but not superior to models containing WHR or EFM, while in those ≥ 50 years, the model with total-cholesterol was superior to all models containing anthropometric variables, whether assessed individually or combined. We found a potential role for replacing total-cholesterol with anthropometric measures for MACE-prediction among individuals < 50 years when laboratory measurements are unavailable, but not among those ≥ 50 years.
First manifestation of cardiovascular disease according to age and sex in a Mediterranean country.
Ortega E, Genua I, Mata-Cases M, Roque M, Vlacho B, Real Gatius J Front Cardiovasc Med. 2024; 11:1403363.
PMID: 39355347 PMC: 11443696. DOI: 10.3389/fcvm.2024.1403363.
Perez-Beltran Y, Gonzalez-Becerra K, Rivera-Iniguez I, Martinez-Lopez E, Ramos-Lopez O, Alcaraz-Mejia M Nutrients. 2023; 15(20).
PMID: 37892400 PMC: 10609523. DOI: 10.3390/nu15204324.
Anti-obesity effect of the bacterial product nisin in an NIH Swiss mouse model.
Al-Emarah M, Kazerani H, Taghizad F, Dehghani H, Elahi M Lipids Health Dis. 2023; 22(1):23.
PMID: 36765351 PMC: 9912503. DOI: 10.1186/s12944-023-01788-1.
Zadarko E, Zadarko-Domaradzka M, Barabasz Z, Sobolewski M Int J Environ Res Public Health. 2022; 19(5).
PMID: 35270329 PMC: 8909649. DOI: 10.3390/ijerph19052643.